Tag: CORO
FDA Approves Emergency Use of Novavax COVID-19 Vaccine
Vaccine is given in two shots, three weeks apart
Asthma Drug Fluticasone Fails as Potential COVID-19 Treatment
Finding from a nationwide study of 5,000 participants that continues to evaluate existing drugs to treat mild-to-moderate COVID-19
Impact of COVID-19 Pandemic on Infection Prevention Professionals Explored
65 percent of respondents reported burnout; more negative mental health impacts seen for frontline and practicing IPs
COVID-19 Incidence Not Increased With Corticosteroid Injections
Incidence of COVID-19 lower for adults receiving image-guided corticosteroid injections for pain management
Spike RBD IgG Antibodies Persist After SARS-CoV-2 Infection
Antibody levels higher for children versus adults across all follow-up time points up to 10 months after infection
Breakthrough Infections in Lupus Patients Down With COVID Booster
Sixty-four percent of those with breakthrough COVID-19 had received booster compared with 82 percent of those without breakthrough infection
Biden Administration May Back Second Booster Shots for All Adults
Expanding eligibility requirements for a fourth dose of the vaccine would require regulatory approval
Infant Hospitalization for COVID-19 Reduced With Maternal Vaccination
Effectiveness of maternal vaccination against COVID-19 hospitalization in infants 80 percent during delta, 38 percent during omicron
New Omicron Subvariant Spreading in India, United States
New mutation -- BA.2.75 -- has been detected in 10 other countries, including Australia, Germany, the United Kingdom, and Canada
Adverse Reactions to BNT162b2 Mild, Moderate for 5- to 11-Year-Olds
Based on data from three U.S. safety monitoring systems, adverse events were mild-to-moderate, and myocarditis occurred rarely